[U.S. Food
and Drug  Administration]

FDA PUBLIC CALENDAR

Food and Drug Administration
Office of Public Affairs
5600 Fishers Lane
Rockville, MD 20857

This public calendar is issued by the Food and Drug Administration. It lists meetings held by the FDA policymakers with persons outside the executive branch of the Federal Government.

Week of February 27 - March 5, 1998

FDA Official and Title Date and SiteOther FDA ParticipantsNon-FDA ParticipantsSubject
Michael A. Friedman, M.D., Lead Deputy Commissioner 3/3 Silver Spring, MD Many from FDA Secretary Shalala, and many others Participated In Innovations in Government Celebration
Sharon Smith Holston, Deputy Commissioner for External Affairs 2/20 Pkln. FDA Officials AMA Officials Conference call on food safety
Sharon Smith Holston, Deputy Commissioner for External Affairs 2/24 Rockville, MD Stephen Goldman, MedWatch; Jerry Phillips, CDER; Mary Gross, OEA Operations Diane Cousins, USP MedMARx
Sharon Smith Holston, Deputy Commissioner for External Affairs 3/2 Pkln. FDA Officials HIMA; Guidant Corp.; Baxter Health Care Corp.; USTR and DoC Officials Discuss the U.S./EU MRA
Audrey Sheppard, Acting Director, Office of Women's Health 3/2 Marietta Anthony, Deborah Smith Cindy Pearson, Executive Director, Lisa Cox, Program Director, Aleah Nesteby, Policy Intern, National Women's Health Network Long Term Contraceptives
Dr. Stephen F. Sundlof, Director, CVM 2/27 Wash., D.C. none Am. Soc. For Microbiology Public and Scientific Affairs Board Antimicrobial resistance
Dr. Stephen F. Sundlof, Director, CVM 3/3 Rockville, MD none Andrew Winstrom, PennField Oil, Co. Pending NADA
Dr. Stephen F. Sundlof, Director, CVM 3/4 Rockville, MD several CVM staff Joel Brandenberger, Natl. Turkey Fed.; Bruce Martin, Elanco; Ron Morris, Tom Knapp, Corwin Knestrick, Wampler Foods Drug Availability
Dr. Kathryn Zoon, Director, CBER 3/4 San Francisco, CA none BIO Board members CBER Science
Dr. Kathryn Zoon, Director, CBER 3/4 San Francisco, CA none BIO Senior Managers Workshop 98 Attendees Current laws and regulations

Return to FDA News Page

March 9, 1998